Skip to main content

Peer Review reports

From: A randomized controlled pilot study of daily intravenous ketamine over three days for treatment-resistant depression

Original Submission
28 Mar 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
15 May 2024 Author responded Author comments - Keerati Pattanaseri
Resubmission - Version 4
15 May 2024 Submitted Manuscript version 4
19 Jun 2024 Reviewed Reviewer Report
20 Jun 2024 Reviewed Reviewer Report - Joseph Tham
1 Jul 2024 Author responded Author comments - Keerati Pattanaseri
Resubmission - Version 5
1 Jul 2024 Submitted Manuscript version 5
Publishing
8 Jul 2024 Editorially accepted
18 Jul 2024 Article published 10.1186/s12888-024-05951-5

You can find further information about peer review here.

Back to article page